Investors in ARS Pharmaceuticals lost more than 23% of their investment value in after-hours trading on June 24, 2026, after the Company disclosed that Neffy® -- its flagship epinephrine nasal spray - ...

Pharmacy benefit managers sit at the center of a four-way transaction between patients, insurers, drug manufacturers, and pharmacies. They’ve figured out how to skim profit from every single one of ...

Please provide your email address to receive an email when new articles are posted on . A federal spending package passed in February takes aim at pharmacy benefit managers. Experts discussed the ...

Express Scripts (Cigna) offers three Medicare Part D prescription drug plans, among other services. Express Scripts Medicare Part D plans range in cost from low premiums and low copays to broad ...

Thank you, Michael. This is an exciting day as it represents our first analyst call reporting on our first ever quarter or, ...

Eli Lilly (LLY) just did something worth paying attention to. With CVS Caremark announcing coverage of both Zepbound and newly approved Foundayo starting this summer, all three of the largest U.S.

CVS Caremark will resume covering the weight loss drug Zepbound this year after it removed it from its list of covered medications last year, drugmaker Eli Lilly said Thursday. CVS Caremark is one of ...

CVS Caremark will resume covering the weight loss drug Zepbound this year after it removed it from its list of covered medications last year, drugmaker Eli Lilly said Thursday. Limited time: Save 25% ...

WASHINGTON – The Federal Trade Commission (FTC) has secured a landmark settlement with one of the nation’s largest pharmacy benefit managers (PBMs), Express Scripts, Inc., and its affiliated entities ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

“This is an exciting day as it represents our first analyst call reporting on our first ever quarter or, more accurately, partial quarter of sales since the commercial launch of CARDAMYST for acute ...